ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1014

Heavy Metals Quantification in Nail Samples from the CRIC Study

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Taylor, Robert M., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Baca, Justin T., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Pankratz, V. Shane, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Yang, Wei, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Wang, Xue, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Unruh, Mark L., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Shah, Vallabh O., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
Background

Chronic kidney disease (CKD) affects >37 million American adults who experience high rates of cardiovascular events, kidney failure, and premature mortality. Recent reports suggest that environmental heavy metal (HM) exposure contributes to the rapid progression of kidney disease. Our overall hypothesis is that cumulative exposure to trace metals increases progression of CKD and higher metal burden will correlate with CKD risk.

Methods

We obtained matching nail samples (n=40) from 20 participants of the Chronic Renal Insufficiency Cohort (CRIC) at baseline (n=20) and 24-month follow-up (n=20). An equal number of subjects had fast progressing disease (EGRF CRIC difference between baseline and follow-up of -1 to 1) (n=10) and stable disease (EGFR CRIC difference between baseline and follow-up <= -10) (n=10). Metal concentrations were analyzed using Inductively Coupled Plasma Mass Spectrometry (ICP/MS). Mercury was measured on a Flow Injector Mercury System (FIMS), and boron was measured using ICP/Optical Emission Spectroscopy (ICP/OES).

Results

We successfully quantified 25 metalloids in all nail samples. Most metalloids had concentrations < 5 µg metalloid / g sample. Aluminum, boron, copper, iron, and zinc had concentrations between 5-80 µg/g. A trend was seen of lower concentrations in the 24-month, compared with the baseline samples. Chromium concentrations in the fast-progressing group were significantly lower at follow up (0.59 ± 0.45 µg/g) versus baseline (2.01 ± 1.64 µg/g) (p=0.036). Average total metal burden (sum of all metal concentrations) across all participants was 520 ± 72 µg/g and 327 ± 40 µg/g for the baseline and 24-month visits, respectively. At baseline, metal burden was 659 ±1006 µg/g and 382 ± 345 µg/g for subjects with fast and slow progressing CKD, respectively. At 2-year follow-up, metal burdens were 313 ± 327 µg/g and 340 ± 415 µg/g, respectively.

Conclusion

All metals we examined were above the limit of detection. Although not significant with a Wilcoxon Rank Sum Test, a trend of higher total metal burden was observed in the rapid progressing cohort, compared with stable progressing cohort.

Funding

  • NIDDK Support